img

Global Amlodipine and Olmesartan Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Amlodipine and Olmesartan Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Amlodipine is a calcium channel blocker. It works by relaxing the muscles of your heart and blood vessels. Olmesartan is an angiotensin II receptor antagonist. Olmesartan keeps blood vessels from narrowing, which lowers blood pressure and improves blood flow. The combination of amlodipine and olmesartan is used to treat high blood pressure (hypertension).
Amlodipine and Olmesartan report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Amlodipine and Olmesartan market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Drug store are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Amlodipine and Olmesartan industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Amlodipine and Olmesartan key manufacturers include Daiichi Sankyo, Teva, Glenmark Pharmaceuticals, Matrix Laboratories, Torrent Pharmaceuticals, Aurobindo, Macleods Pharmaceuticals, Alembic Pharmaceuticals and Ajanta Pharma, etc. Daiichi Sankyo, Teva, Glenmark Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Amlodipine and Olmesartan can be divided into 5/20 mg Tablets, 10/20 mg Tablets, 5/40 mg Tablets and 10/40 mg Tablets, etc. 5/20 mg Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Amlodipine and Olmesartan is widely used in various fields, such as Hospital and Drug store, etc. Hospital provides greatest supports to the Amlodipine and Olmesartan industry development. In 2022, global % sales of Amlodipine and Olmesartan went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Amlodipine and Olmesartan market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Daiichi Sankyo
Teva
Glenmark Pharmaceuticals
Matrix Laboratories
Torrent Pharmaceuticals
Aurobindo
Macleods Pharmaceuticals
Alembic Pharmaceuticals
Ajanta Pharma
Jubilant Pharma
Accord Healthcare
Segment by Type
5/20 mg Tablets
10/20 mg Tablets
5/40 mg Tablets
10/40 mg Tablets

Segment by Application


Hospital
Drug store

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Amlodipine and Olmesartan market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Amlodipine and Olmesartan, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Amlodipine and Olmesartan industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Amlodipine and Olmesartan in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Amlodipine and Olmesartan introduction, etc. Amlodipine and Olmesartan Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Amlodipine and Olmesartan market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Amlodipine and Olmesartan Market Overview
1.1 Amlodipine and Olmesartan Product Overview
1.2 Amlodipine and Olmesartan Market Segment by Type
1.2.1 5/20 mg Tablets
1.2.2 10/20 mg Tablets
1.2.3 5/40 mg Tablets
1.2.4 10/40 mg Tablets
1.3 Global Amlodipine and Olmesartan Market Size by Type
1.3.1 Global Amlodipine and Olmesartan Market Size Overview by Type (2018-2034)
1.3.2 Global Amlodipine and Olmesartan Historic Market Size Review by Type (2018-2024)
1.3.3 Global Amlodipine and Olmesartan Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Amlodipine and Olmesartan Sales Breakdown by Type (2018-2024)
1.4.2 Europe Amlodipine and Olmesartan Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Amlodipine and Olmesartan Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Amlodipine and Olmesartan Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Amlodipine and Olmesartan Sales Breakdown by Type (2018-2024)
2 Global Amlodipine and Olmesartan Market Competition by Company
2.1 Global Top Players by Amlodipine and Olmesartan Sales (2018-2024)
2.2 Global Top Players by Amlodipine and Olmesartan Revenue (2018-2024)
2.3 Global Top Players by Amlodipine and Olmesartan Price (2018-2024)
2.4 Global Top Manufacturers Amlodipine and Olmesartan Manufacturing Base Distribution, Sales Area, Product Type
2.5 Amlodipine and Olmesartan Market Competitive Situation and Trends
2.5.1 Amlodipine and Olmesartan Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Amlodipine and Olmesartan Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amlodipine and Olmesartan as of 2022)
2.7 Date of Key Manufacturers Enter into Amlodipine and Olmesartan Market
2.8 Key Manufacturers Amlodipine and Olmesartan Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Amlodipine and Olmesartan Status and Outlook by Region
3.1 Global Amlodipine and Olmesartan Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Amlodipine and Olmesartan Historic Market Size by Region
3.2.1 Global Amlodipine and Olmesartan Sales in Volume by Region (2018-2024)
3.2.2 Global Amlodipine and Olmesartan Sales in Value by Region (2018-2024)
3.2.3 Global Amlodipine and Olmesartan Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Amlodipine and Olmesartan Forecasted Market Size by Region
3.3.1 Global Amlodipine and Olmesartan Sales in Volume by Region (2024-2034)
3.3.2 Global Amlodipine and Olmesartan Sales in Value by Region (2024-2034)
3.3.3 Global Amlodipine and Olmesartan Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Amlodipine and Olmesartan by Application
4.1 Amlodipine and Olmesartan Market Segment by Application
4.1.1 Hospital
4.1.2 Drug store
4.2 Global Amlodipine and Olmesartan Market Size by Application
4.2.1 Global Amlodipine and Olmesartan Market Size Overview by Application (2018-2034)
4.2.2 Global Amlodipine and Olmesartan Historic Market Size Review by Application (2018-2024)
4.2.3 Global Amlodipine and Olmesartan Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Amlodipine and Olmesartan Sales Breakdown by Application (2018-2024)
4.3.2 Europe Amlodipine and Olmesartan Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Amlodipine and Olmesartan Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Amlodipine and Olmesartan Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Amlodipine and Olmesartan Sales Breakdown by Application (2018-2024)
5 North America Amlodipine and Olmesartan by Country
5.1 North America Amlodipine and Olmesartan Historic Market Size by Country
5.1.1 North America Amlodipine and Olmesartan Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Amlodipine and Olmesartan Sales in Volume by Country (2018-2024)
5.1.3 North America Amlodipine and Olmesartan Sales in Value by Country (2018-2024)
5.2 North America Amlodipine and Olmesartan Forecasted Market Size by Country
5.2.1 North America Amlodipine and Olmesartan Sales in Volume by Country (2024-2034)
5.2.2 North America Amlodipine and Olmesartan Sales in Value by Country (2024-2034)
6 Europe Amlodipine and Olmesartan by Country
6.1 Europe Amlodipine and Olmesartan Historic Market Size by Country
6.1.1 Europe Amlodipine and Olmesartan Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Amlodipine and Olmesartan Sales in Volume by Country (2018-2024)
6.1.3 Europe Amlodipine and Olmesartan Sales in Value by Country (2018-2024)
6.2 Europe Amlodipine and Olmesartan Forecasted Market Size by Country
6.2.1 Europe Amlodipine and Olmesartan Sales in Volume by Country (2024-2034)
6.2.2 Europe Amlodipine and Olmesartan Sales in Value by Country (2024-2034)
7 Asia-Pacific Amlodipine and Olmesartan by Region
7.1 Asia-Pacific Amlodipine and Olmesartan Historic Market Size by Region
7.1.1 Asia-Pacific Amlodipine and Olmesartan Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Amlodipine and Olmesartan Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Amlodipine and Olmesartan Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Amlodipine and Olmesartan Forecasted Market Size by Region
7.2.1 Asia-Pacific Amlodipine and Olmesartan Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Amlodipine and Olmesartan Sales in Value by Region (2024-2034)
8 Latin America Amlodipine and Olmesartan by Country
8.1 Latin America Amlodipine and Olmesartan Historic Market Size by Country
8.1.1 Latin America Amlodipine and Olmesartan Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Amlodipine and Olmesartan Sales in Volume by Country (2018-2024)
8.1.3 Latin America Amlodipine and Olmesartan Sales in Value by Country (2018-2024)
8.2 Latin America Amlodipine and Olmesartan Forecasted Market Size by Country
8.2.1 Latin America Amlodipine and Olmesartan Sales in Volume by Country (2024-2034)
8.2.2 Latin America Amlodipine and Olmesartan Sales in Value by Country (2024-2034)
9 Middle East and Africa Amlodipine and Olmesartan by Country
9.1 Middle East and Africa Amlodipine and Olmesartan Historic Market Size by Country
9.1.1 Middle East and Africa Amlodipine and Olmesartan Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Amlodipine and Olmesartan Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Amlodipine and Olmesartan Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Amlodipine and Olmesartan Forecasted Market Size by Country
9.2.1 Middle East and Africa Amlodipine and Olmesartan Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Amlodipine and Olmesartan Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Daiichi Sankyo
10.1.1 Daiichi Sankyo Company Information
10.1.2 Daiichi Sankyo Introduction and Business Overview
10.1.3 Daiichi Sankyo Amlodipine and Olmesartan Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Daiichi Sankyo Amlodipine and Olmesartan Products Offered
10.1.5 Daiichi Sankyo Recent Development
10.2 Teva
10.2.1 Teva Company Information
10.2.2 Teva Introduction and Business Overview
10.2.3 Teva Amlodipine and Olmesartan Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Teva Amlodipine and Olmesartan Products Offered
10.2.5 Teva Recent Development
10.3 Glenmark Pharmaceuticals
10.3.1 Glenmark Pharmaceuticals Company Information
10.3.2 Glenmark Pharmaceuticals Introduction and Business Overview
10.3.3 Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Glenmark Pharmaceuticals Amlodipine and Olmesartan Products Offered
10.3.5 Glenmark Pharmaceuticals Recent Development
10.4 Matrix Laboratories
10.4.1 Matrix Laboratories Company Information
10.4.2 Matrix Laboratories Introduction and Business Overview
10.4.3 Matrix Laboratories Amlodipine and Olmesartan Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Matrix Laboratories Amlodipine and Olmesartan Products Offered
10.4.5 Matrix Laboratories Recent Development
10.5 Torrent Pharmaceuticals
10.5.1 Torrent Pharmaceuticals Company Information
10.5.2 Torrent Pharmaceuticals Introduction and Business Overview
10.5.3 Torrent Pharmaceuticals Amlodipine and Olmesartan Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Torrent Pharmaceuticals Amlodipine and Olmesartan Products Offered
10.5.5 Torrent Pharmaceuticals Recent Development
10.6 Aurobindo
10.6.1 Aurobindo Company Information
10.6.2 Aurobindo Introduction and Business Overview
10.6.3 Aurobindo Amlodipine and Olmesartan Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Aurobindo Amlodipine and Olmesartan Products Offered
10.6.5 Aurobindo Recent Development
10.7 Macleods Pharmaceuticals
10.7.1 Macleods Pharmaceuticals Company Information
10.7.2 Macleods Pharmaceuticals Introduction and Business Overview
10.7.3 Macleods Pharmaceuticals Amlodipine and Olmesartan Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Macleods Pharmaceuticals Amlodipine and Olmesartan Products Offered
10.7.5 Macleods Pharmaceuticals Recent Development
10.8 Alembic Pharmaceuticals
10.8.1 Alembic Pharmaceuticals Company Information
10.8.2 Alembic Pharmaceuticals Introduction and Business Overview
10.8.3 Alembic Pharmaceuticals Amlodipine and Olmesartan Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Alembic Pharmaceuticals Amlodipine and Olmesartan Products Offered
10.8.5 Alembic Pharmaceuticals Recent Development
10.9 Ajanta Pharma
10.9.1 Ajanta Pharma Company Information
10.9.2 Ajanta Pharma Introduction and Business Overview
10.9.3 Ajanta Pharma Amlodipine and Olmesartan Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Ajanta Pharma Amlodipine and Olmesartan Products Offered
10.9.5 Ajanta Pharma Recent Development
10.10 Jubilant Pharma
10.10.1 Jubilant Pharma Company Information
10.10.2 Jubilant Pharma Introduction and Business Overview
10.10.3 Jubilant Pharma Amlodipine and Olmesartan Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Jubilant Pharma Amlodipine and Olmesartan Products Offered
10.10.5 Jubilant Pharma Recent Development
10.11 Accord Healthcare
10.11.1 Accord Healthcare Company Information
10.11.2 Accord Healthcare Introduction and Business Overview
10.11.3 Accord Healthcare Amlodipine and Olmesartan Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Accord Healthcare Amlodipine and Olmesartan Products Offered
10.11.5 Accord Healthcare Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Amlodipine and Olmesartan Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Amlodipine and Olmesartan Industrial Chain Analysis
11.4 Amlodipine and Olmesartan Market Dynamics
11.4.1 Amlodipine and Olmesartan Industry Trends
11.4.2 Amlodipine and Olmesartan Market Drivers
11.4.3 Amlodipine and Olmesartan Market Challenges
11.4.4 Amlodipine and Olmesartan Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Amlodipine and Olmesartan Distributors
12.3 Amlodipine and Olmesartan Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 5/20 mg Tablets
Table 2. Major Company of 10/20 mg Tablets
Table 3. Major Company of 5/40 mg Tablets
Table 4. Major Company of 10/40 mg Tablets
Table 5. Global Amlodipine and Olmesartan Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Amlodipine and Olmesartan Sales by Type (2018-2024) & (K Units)
Table 7. Global Amlodipine and Olmesartan Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Amlodipine and Olmesartan Sales by Type (2018-2024) & (US& Million)
Table 9. Global Amlodipine and Olmesartan Market Share in Value by Type (2018-2024)
Table 10. Global Amlodipine and Olmesartan Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Amlodipine and Olmesartan Sales by Type (2024-2034) & (K Units)
Table 12. Global Amlodipine and Olmesartan Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Amlodipine and Olmesartan Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Amlodipine and Olmesartan Sales Market Share in Value by Type (2024-2034)
Table 15. Global Amlodipine and Olmesartan Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Amlodipine and Olmesartan Sales by Type (2018-2024) & (K Units)
Table 17. North America Amlodipine and Olmesartan Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Amlodipine and Olmesartan Sales (K Units) by Type (2018-2024)
Table 19. Europe Amlodipine and Olmesartan Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Amlodipine and Olmesartan Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Amlodipine and Olmesartan Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Amlodipine and Olmesartan Sales (K Units) by Type (2018-2024)
Table 23. Latin America Amlodipine and Olmesartan Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Amlodipine and Olmesartan Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Amlodipine and Olmesartan Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Amlodipine and Olmesartan Sales by Company (2018-2024) & (K Units)
Table 27. Global Amlodipine and Olmesartan Sales Share by Company (2018-2024)
Table 28. Global Amlodipine and Olmesartan Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Amlodipine and Olmesartan Revenue Share by Company (2018-2024)
Table 30. Global Market Amlodipine and Olmesartan Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Amlodipine and Olmesartan Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Amlodipine and Olmesartan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Amlodipine and Olmesartan as of 2022)
Table 34. Date of Key Manufacturers Enter into Amlodipine and Olmesartan Market
Table 35. Key Manufacturers Amlodipine and Olmesartan Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Amlodipine and Olmesartan Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Amlodipine and Olmesartan Sales by Region (2018-2024) & (K Units)
Table 39. Global Amlodipine and Olmesartan Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Amlodipine and Olmesartan Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Amlodipine and Olmesartan Sales Market Share in Value by Region (2018-2024)
Table 42. Global Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Amlodipine and Olmesartan Sales by Region (2024-2034) & (K Units)
Table 44. Global Amlodipine and Olmesartan Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Amlodipine and Olmesartan Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Amlodipine and Olmesartan Sales Market Share in Value by Region (2024-2034)
Table 47. Global Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Amlodipine and Olmesartan Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Amlodipine and Olmesartan Sales by Application (2018-2024) & (K Units)
Table 50. Global Amlodipine and Olmesartan Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Amlodipine and Olmesartan Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Amlodipine and Olmesartan Sales Market Share in Value by Application (2018-2024)
Table 53. Global Amlodipine and Olmesartan Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Amlodipine and Olmesartan Sales by Application (2024-2034) & (K Units)
Table 55. Global Amlodipine and Olmesartan Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Amlodipine and Olmesartan Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Amlodipine and Olmesartan Sales Market Share in Value by Application (2024-2034)
Table 58. Global Amlodipine and Olmesartan Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Amlodipine and Olmesartan Sales by Application (2018-2024) (K Units)
Table 60. North America Amlodipine and Olmesartan Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Amlodipine and Olmesartan Sales by Application (2018-2024) (K Units)
Table 62. Europe Amlodipine and Olmesartan Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Amlodipine and Olmesartan Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Amlodipine and Olmesartan Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Amlodipine and Olmesartan Sales by Application (2018-2024) (K Units)
Table 66. Latin America Amlodipine and Olmesartan Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Amlodipine and Olmesartan Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Amlodipine and Olmesartan Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Amlodipine and Olmesartan Sales by Country (2018-2024) & (K Units)
Table 70. North America Amlodipine and Olmesartan Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Amlodipine and Olmesartan Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Amlodipine and Olmesartan Sales Market Share in Value by Country (2018-2024)
Table 73. North America Amlodipine and Olmesartan Sales by Country (2024-2034) & (K Units)
Table 74. North America Amlodipine and Olmesartan Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Amlodipine and Olmesartan Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Amlodipine and Olmesartan Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Amlodipine and Olmesartan Sales by Country (2018-2024) & (K Units)
Table 78. Europe Amlodipine and Olmesartan Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Amlodipine and Olmesartan Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Amlodipine and Olmesartan Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Amlodipine and Olmesartan Sales by Country (2024-2034) & (K Units)
Table 82. Europe Amlodipine and Olmesartan Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Amlodipine and Olmesartan Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Amlodipine and Olmesartan Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Amlodipine and Olmesartan Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Amlodipine and Olmesartan Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Amlodipine and Olmesartan Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Amlodipine and Olmesartan Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Amlodipine and Olmesartan Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Amlodipine and Olmesartan Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Amlodipine and Olmesartan Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Amlodipine and Olmesartan Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Amlodipine and Olmesartan Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Amlodipine and Olmesartan Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Amlodipine and Olmesartan Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Amlodipine and Olmesartan Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Amlodipine and Olmesartan Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Amlodipine and Olmesartan Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Amlodipine and Olmesartan Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Amlodipine and Olmesartan Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Amlodipine and Olmesartan Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Amlodipine and Olmesartan Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Amlodipine and Olmesartan Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Amlodipine and Olmesartan Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Amlodipine and Olmesartan Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Amlodipine and Olmesartan Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Amlodipine and Olmesartan Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Amlodipine and Olmesartan Sales Market Share in Value by Country (2024-2034)
Table 109. Daiichi Sankyo Company Information
Table 110. Daiichi Sankyo Introduction and Business Overview
Table 111. Daiichi Sankyo Amlodipine and Olmesartan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Daiichi Sankyo Amlodipine and Olmesartan Product
Table 113. Daiichi Sankyo Recent Development
Table 114. Teva Company Information
Table 115. Teva Introduction and Business Overview
Table 116. Teva Amlodipine and Olmesartan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Teva Amlodipine and Olmesartan Product
Table 118. Teva Recent Development
Table 119. Glenmark Pharmaceuticals Company Information
Table 120. Glenmark Pharmaceuticals Introduction and Business Overview
Table 121. Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Glenmark Pharmaceuticals Amlodipine and Olmesartan Product
Table 123. Glenmark Pharmaceuticals Recent Development
Table 124. Matrix Laboratories Company Information
Table 125. Matrix Laboratories Introduction and Business Overview
Table 126. Matrix Laboratories Amlodipine and Olmesartan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Matrix Laboratories Amlodipine and Olmesartan Product
Table 128. Matrix Laboratories Recent Development
Table 129. Torrent Pharmaceuticals Company Information
Table 130. Torrent Pharmaceuticals Introduction and Business Overview
Table 131. Torrent Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Torrent Pharmaceuticals Amlodipine and Olmesartan Product
Table 133. Torrent Pharmaceuticals Recent Development
Table 134. Aurobindo Company Information
Table 135. Aurobindo Introduction and Business Overview
Table 136. Aurobindo Amlodipine and Olmesartan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Aurobindo Amlodipine and Olmesartan Product
Table 138. Aurobindo Recent Development
Table 139. Macleods Pharmaceuticals Company Information
Table 140. Macleods Pharmaceuticals Introduction and Business Overview
Table 141. Macleods Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Macleods Pharmaceuticals Amlodipine and Olmesartan Product
Table 143. Macleods Pharmaceuticals Recent Development
Table 144. Alembic Pharmaceuticals Company Information
Table 145. Alembic Pharmaceuticals Introduction and Business Overview
Table 146. Alembic Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Alembic Pharmaceuticals Amlodipine and Olmesartan Product
Table 148. Alembic Pharmaceuticals Recent Development
Table 149. Ajanta Pharma Company Information
Table 150. Ajanta Pharma Introduction and Business Overview
Table 151. Ajanta Pharma Amlodipine and Olmesartan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Ajanta Pharma Amlodipine and Olmesartan Product
Table 153. Ajanta Pharma Recent Development
Table 154. Jubilant Pharma Company Information
Table 155. Jubilant Pharma Introduction and Business Overview
Table 156. Jubilant Pharma Amlodipine and Olmesartan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Jubilant Pharma Amlodipine and Olmesartan Product
Table 158. Jubilant Pharma Recent Development
Table 159. Accord Healthcare Company Information
Table 160. Accord Healthcare Introduction and Business Overview
Table 161. Accord Healthcare Amlodipine and Olmesartan Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Accord Healthcare Amlodipine and Olmesartan Product
Table 163. Accord Healthcare Recent Development
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Amlodipine and Olmesartan Market Trends
Table 167. Amlodipine and Olmesartan Market Drivers
Table 168. Amlodipine and Olmesartan Market Challenges
Table 169. Amlodipine and Olmesartan Market Restraints
Table 170. Amlodipine and Olmesartan Distributors List
Table 171. Amlodipine and Olmesartan Downstream Customers
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Amlodipine and Olmesartan Product Picture
Figure 2. Global Amlodipine and Olmesartan Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Amlodipine and Olmesartan Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Amlodipine and Olmesartan Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of 5/20 mg Tablets
Figure 6. Global 5/20 mg Tablets Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of 10/20 mg Tablets
Figure 8. Global 10/20 mg Tablets Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of 5/40 mg Tablets
Figure 10. Global 5/40 mg Tablets Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of 10/40 mg Tablets
Figure 12. Global 10/40 mg Tablets Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Amlodipine and Olmesartan Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Amlodipine and Olmesartan Sales Market Share by Type in 2022 & 2034
Figure 15. North America Amlodipine and Olmesartan Sales Market Share in Volume by Type in 2022
Figure 16. North America Amlodipine and Olmesartan Sales Market Share in Value by Type in 2022
Figure 17. Europe Amlodipine and Olmesartan Sales Market Share in Volume by Type in 2022
Figure 18. Europe Amlodipine and Olmesartan Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Amlodipine and Olmesartan Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Amlodipine and Olmesartan Sales Market Share in Value by Type in 2022
Figure 21. Latin America Amlodipine and Olmesartan Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Amlodipine and Olmesartan Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Amlodipine and Olmesartan Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Amlodipine and Olmesartan Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Amlodipine and Olmesartan Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Amlodipine and Olmesartan Revenue in 2022
Figure 27. Amlodipine and Olmesartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Drug store
Figure 31. Global Drug store Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global Amlodipine and Olmesartan Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Amlodipine and Olmesartan Sales Market Share by Application in 2022 & 2034
Figure 34. North America Amlodipine and Olmesartan Sales Market Share in Volume by Application in 2022
Figure 35. North America Amlodipine and Olmesartan Sales Market Share in Value by Application in 2022
Figure 36. Europe Amlodipine and Olmesartan Sales Market Share in Volume by Application in 2022
Figure 37. Europe Amlodipine and Olmesartan Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Amlodipine and Olmesartan Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Amlodipine and Olmesartan Sales Market Share in Value by Application in 2022
Figure 40. Latin America Amlodipine and Olmesartan Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Amlodipine and Olmesartan Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Amlodipine and Olmesartan Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Amlodipine and Olmesartan Manufacturing Cost Structure
Figure 45. Amlodipine and Olmesartan Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries